1989
DOI: 10.1172/jci114079
|View full text |Cite
|
Sign up to set email alerts
|

Glomerular actions of endothelin in vivo.

Abstract: In Munich-Wistar rats, a micropipette was inserted into a first-order branch of the left main renal artery and continuously infused with human/porcine endothelin (0.4 ng/min). Micropuncture measurements revealed substantial differences within the cortical microcirculation of the same left kidney: SNGFR was some 35% lower in glomeruli exposed to endothelin compared with non-endothelin-perfused glomeruli (P < 0.005). Similarly, glomerular plasma flow rate was some 38% lower in the endothelin-exposed glomeruli (P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
128
3
3

Year Published

1991
1991
2011
2011

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 339 publications
(141 citation statements)
references
References 16 publications
7
128
3
3
Order By: Relevance
“…A 1:20,000 dilution of antiserum binds approximately 50% of radiolabeled endothelin at a concentration of 1.0 pmol/ml. The antiserum was diluted 1:100 with phosphate buffer solution (pH 7.40) and was infused intraluminally 25 through the polyethylene catheter in the afferent cannula, which was connected to a syringe on a microinfusion pump (model 22, Harvard Apparatus, South Natick, Mass.). For the intraluminal application of the antiserum, flow rate through the vascular segment was measured repeatedly at the efferent cannula (since flow changes with changes in vascular diameter), and infusion rate of intraluminally applied drug was adjusted accordingly to assure a constant concentration of the drug in perfusate.…”
Section: Protocolsmentioning
confidence: 99%
“…A 1:20,000 dilution of antiserum binds approximately 50% of radiolabeled endothelin at a concentration of 1.0 pmol/ml. The antiserum was diluted 1:100 with phosphate buffer solution (pH 7.40) and was infused intraluminally 25 through the polyethylene catheter in the afferent cannula, which was connected to a syringe on a microinfusion pump (model 22, Harvard Apparatus, South Natick, Mass.). For the intraluminal application of the antiserum, flow rate through the vascular segment was measured repeatedly at the efferent cannula (since flow changes with changes in vascular diameter), and infusion rate of intraluminally applied drug was adjusted accordingly to assure a constant concentration of the drug in perfusate.…”
Section: Protocolsmentioning
confidence: 99%
“…ET-I showed various pharmacological activities in both cardiovascular and non-cardiovascular tissues [3]. Especially, ET-I is thought to play important roles in the kidney in the control of mesangial cell function, glomerular filtration rate, renal vascular tone [4] and ion transport/water permeability [5].…”
Section: Introductionmentioning
confidence: 99%
“…39 Because hypoxia is a potent stimulus of ET release, Firth et al 40 suggested that ET mediates hemodynamically induced acute renal failure. Support for this view comes from the work of Kon and coworkers, 41 who showed in a model of postischemic renal injury that ET-neutralizing antibodies reverse the reduction in single nephron glomerular filtration rate and renal blood flow. Thus, ET released by damaged endothelium or mesangial cells might contribute to the hypoperfusion and hypofiltration seen in postischemic renal injury.…”
mentioning
confidence: 98%